Mary E Hamby

7PUBLICATIONS
11CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesGene and molecular therapyMolecular medicinePsychology of ageing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2026
Crystal Structure of the Sigma‑2 Receptor Complexed with Investigational Drug Zervimesine (CT1812).

|Apr 03, 2026
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease.

Everard G B Vijverberg, Douglas W Scharre, Michael Woodward

|Jun 23, 2025
Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812.

Valentina Di Caro, Eunah Cho, Hilary A North

|Aug 21, 2024
CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease.

Britney N Lizama, Claire Williams, Hilary A North

|Apr 13, 2023
Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases.

Britney N Lizama, Jennifer Kahle, Susan M Catalano

|Jul 15, 2020
Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic Functions.

Sunil Goodwani, Celia Fernandez, Paul J Acton

Pageof 2

Frequent Collaborators

1 joint publications

Sunil Goodwani

1 joint publications

Jiacheng Ma

1 joint publications

Cheng Hui Hu

1 joint publications

Britney N Lizama